Muscle Relaxants Flashcards

1
Q

Succinylcholine:
Dose, onset, duration

A

0.6-1.5mg/kg
Less than 1 minute
5 to 10 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Succinylcholine phases

A
  • 1 - depolarization with fasciculations
  • 2 - repolarization - dose exceeds 2-4mg/kg
    Potassium goes up 0.5mEq/L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Succinylcholine metabolism

A

Pseudocholinesterase

Can be affected by liver disease, anticholinesterases, chemotherapeutic drugs

Atypical plasma cholinesterase can not hydrolyze succinylcholine

Only discovered when more than 1 hour of skeletal muscle paralysis occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DMR Side effects

A

Cardiac dysrhythmias
Hyperkalemia
Myalgia
Myoglobinuria
Increased intraocular, intragastric, intracranial pressure
Trismus

Use atropine to decrease the cardiac effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NDMR Classification:

A

Long - d-tubocurarine, metocurine, gallamine, pancuronium, pipecuronium, doxacurium - 3 to 5 - 60 to 90

Intermediate - atracurium, vecuronium, rocuronium

Short - mivacurium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mivacurium:

A

6 to 16 min
Plasma cholinesterase
Some histamine release ,- avoid in asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is pancuronium unique?

A

Increases HR, BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Enhance NDMR effect:

A

VA, aminoglycosides, magnesium, local anesthetics, cardiac antiarrhythmics, calcium blockers

Hypothermia

Reduced pH

Hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How to antagonize NMDR?

A

Anticholiesterases like neostigmine, pyridostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Suggamadex:

A

Reverses NM blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Suggamadex contraindication:

A

Renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Malignant hyperthermia diagnosis:

A

Muscle biopsy using the in vitro contracture test:
- femoral nerve block
- remove 8-10 muscle speciments (3-4cm long) from the vastus medialis muscle
- Positive diagnosis if the muscle contracts in response to caffeine or halothane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Signs of malignant hyperthermia:

A
  • Sustained jaw rigidity
  • Unexplained tachycardia w/ an unexpected rise in ETCO2 or minute volume
  • Falling SaO2 despite increased FiO2
  • CVS instability
  • Generalized rigidity
  • Core temperature rise of 2C per hour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to manage a patient with a history of malignant hyperthermia?

A
  • Avoid succinylcholine and volatile anesthetics
  • Baseline core temperature and measuring of core temperature
  • Dantrolene should be handy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

One of the more serious effects of succinylcholine is ___________
This effect can be reduced by administration with _______

A

Cardiac dysrhythmias
Atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Effects of succinylcholine

A

Cardiac dyr
INhythmias
Hyperkalemia
Myoglobinuria
Increased intraocular pressure
Increased intragastric pressure
Increased intracranial pressure
Trismus (especially in pediatrics)

17
Q

Pharmacokinetics of NDMR’s:

A
  • Highly ionized and possess limited lipid solubility
  • Can not easily pass lipid membranes
  • Do not produce CNS effects
  • Renal tubular reabsorption is minimum
  • Oral administration is not effective
  • Maternal administration does not affect the fetus
18
Q

Long-acting NDMR doses:

A

D-Tubocurarine - 0.51 mg/kg
Metocurine - 0.28mg/kg
Gallamine 1.0mg/kg
Pancuronium - 0.07mg/kg
Pipecuronium - 0.07mg/kg
Doxacurium - 0.25-0.40mg/kg

19
Q

Intermediate-acting NMDR doses:

A

Atracurium - 0.3-0.6mg/kg
Cisatracurium - 150ug/kg
Vecuronium 80-100ug/kg
Rocuronium - 0.6-1.0mg/kg

20
Q

Mivacurium dose, kinetics

A

Intubation - 0.07-0.25mg/kg
Infusion- 0.4-0.6mg/kg/h

6-16mins
Some histamine release, avoid in asthma

21
Q

Factors enhancing NDMR effects:

A
  • Drugs - VA’s, AG AB’s, Mg, local anesthetics, antiarrhythmics, CCB’s
  • Hypothermia
  • Reduced pH
  • Hypokalemia
22
Q

Test to determine fi there is no significant NM block:

A
  • Head lift
23
Q

Anticholinesterases like _______ can cause _____ this can be prevented with use of _________

A

neostigmine
pyridostigmine
bradycardia
atropine

24
Q

Suggamadex use and contraindication

A

Reversal of NM blockade by NDMR
Do not use with renal disease

25
Q

In vitro contracture test:
Performed under ______
8-10 segments about 3-4cm long are removed from the __________
Diagnosis is considred positive if the muscle contracts in response to________

A

Femoral nerve block
Vastus medialis muscle
Caffeine or halothane

26
Q

Signs of MH:

A
  • Muscle rigidity
  • Jaw rigidity
  • Unexpected tachycardia w/ unexpected rise in ETCO2
  • Falling SaO2 but increase in FiO2
  • Cardiovascular instability
  • Generalized rigidity
  • Core temperature rises 2C per hour
27
Q

A patient is experiencing symptoms of MH during surgery, what do we do?

A

Stop giving the causative medication
Give 100% oxygen
Give dantrolene 1mg/kg - usually require 2.4mg/kg, up to 10mg/kg can be used
Reduce core temperature with cold fluid IV
Correct acidosis and hyperkalemia